Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...

Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The ...

The price target boosts come after LLY stock rose 30% during November amid a strong rally in the shares. The bull run comes after Eli Lilly reported strong third-quarter financial results and struck a ...

On December 16, Daiwa analyst Narumi Nakagiri upgraded Eli Lilly and Company (NYSE:LLY) to Buy from Neutral and set a $1,230 ...

UnitedHealth Group (UNH 1.05%) and Eli Lilly (LLY +1.45%) are two of the largest and most powerful healthcare companies in ...

Eli Lilly's shares may appear expensive at first glance, but a closer look reveals a different story. The company's outlook ...

The average one-year price target for Eli Lilly and (NYSE:LLY) has been revised to $1,020.92 / share. This is an increase of 10.15% from the prior estimate of $926.82 dated November 7, 2025. The price ...

Eli Lilly and Company’s LLY stock has risen 18% in a month, driven mainly by a stellar third-quarter performance. Also, earlier this month, President Trump announced deals with Lilly and rival Novo ...

Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...

Eli Lilly has officially entered the most exclusive club in corporate America, crossing the trillion-dollar market capitalization threshold and cementing its status among the world’s most valuable ...